...
首页> 外文期刊>Key Engineering Materials >Enzyme-Resistant Starch for Oral Colon-Targeting Drug Delivery System
【24h】

Enzyme-Resistant Starch for Oral Colon-Targeting Drug Delivery System

机译:口服结肠靶向药物递送系统的抗酶淀粉

获取原文
获取原文并翻译 | 示例
           

摘要

Colon-targeting drug delivery systems (CDDSs) are employed to improve the bioavailability of protein and peptide drugs through the oral route. So it is important to prepare the drug carriers for oral CDDS. In this study, the Enzyme-Resistant starch (RS) was studied for use as a vehicle in oral colon-targeting drag delivery. The characteristics of RS powders were investigated by X-ray diffraction, polarizing microscopy, DSC and SEM, and their film were examined by enzymatic digestion test. The results showed that RS could be a promising film-former for pharmaceutical coatings, having good stability to enzymatic digestion. Furthermore, a novel peroral formulation using RS coating and bovine serum albumin as a model drag was studied for colon-specific drag delivery in vitro. Drag release studies have shown that RS coating could delivery the drag to the colon and the release rate in simulated colonic fluids was dependent on the biodegradation of RS and its coatings. It is indicated that the RS coated tablet is a potential system for oral CDDS.
机译:结肠靶向药物递送系统(CDDS)用于通过口服途径改善蛋白质和肽类药物的生物利用度。因此,为口服CDDS准备药物载体非常重要。在这项研究中,耐酶淀粉(RS)被研究用作口服结肠靶向药物的载体。通过X射线衍射,偏光显微镜,DSC和SEM研究了RS粉末的特性,并通过酶消化试验检查了它们的膜。结果表明,RS具有良好的酶消化稳定性,可以作为药物涂层的成膜剂。此外,研究了使用RS涂层和牛血清白蛋白作为模型药物的新型口服制剂,用于体外结肠特异性药物递送。阻力释放研究表明,RS涂层可以将阻力传递到结肠,模拟结肠液中的释放速率取决于RS及其涂层的生物降解。表明RS包衣片剂是口服CDDS的潜在系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号